Stat News: Drug makers question idea to shake up how Medicare pays for certain drugs
PCMA said the changes wouldn’t be as disruptive as others argued, and highlighted several classes of drugs
PCMA said the changes wouldn’t be as disruptive as others argued, and highlighted several classes of drugs
Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year
Mark Merritt said “we always support, as an industry, patients paying lower price at the counter…it’s an outlier practice.”
Greater competition is the answer, Mr. Merritt said, and he praised recent efforts by the Food and Drug Administration
Upcoming Events Events 10 Nov 10 Nov – 11 Nov Test 2021-11-10 01:00 AM – 2021-11-11 03:00 AM Online Event PCMA Spring Webinar Series 2020 The live webinar series is designed to highlight drug supply chain executives’ thoughts and strategies
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
Christina Perkins Manager, Accounting Christina Perkins is Manager of Accounting at PCMA. In this role, she helps to maintain the company’s financials. Christina has over fifteen years of experience in accounting, holding various positions throughout her career. Christina most recently
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing, “The Need to Make Insulin Affordable for All Americans,”
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. Pandemic Vaccine: Safety Top Priority for Rx Supply Chain… As states
©2024 PCMA. All Rights Reserved.